Eli Lilly has announced plans to expand its domestic medicine production in the US by establishing four new pharmaceutical manufacturing sites. The move increases the company's total US capital ...

Eli Lilly has unveiled plans to invest at least $27bn in building four new pharmaceutical manufacturing sites in the US.

Eli Lilly will spend $3 billion expanding a recently ... Lilly bought the plant in Pleasant Prairie, Kenosha County earlier this year from Nexus Pharma as part of a massive manufacturing ...

The new manufacturing sites are expected to create create 3,000 pharmaceutical jobs and nearly 10,000 construction positions during the buildout.

Eli Lilly (LLY) and Company announced at plans to bolster its domestic medicine production across therapeutic areas by building four new ...

Over the last few years, as Eli Lilly has revealed a series of manufacturing ... $3 billion into upgrading the injectables plant in Kenosha, Wis. that it had bought from Nexus Pharmaceuticals ...

Eli Lilly (NYSE:LLY) recently announced its plans to invest $27 billion in four new U.S. manufacturing plants over the next five years, creating thousands of jobs. This move comes at a time when ...

Eli Lilly has announced plans to expand its domestic ... and the acquisition and expansion of a manufacturing site in Kenosha County, Wisconsin. In August 2024, the company opened the research ...

Indianapolis-based pharmaceutical giant Eli Lilly and Co. announced plans Wednesday ... and the acquisition and expansion of its manufacturing site in Kenosha County, Wisconsin.